Mutation and linkage analysis of CDKN2A and CDK4 in 119 Australian melanoma kindreds.

被引：0
|
作者：
Mann, GJ [1 ]
Holland, EA [1 ]
Becker, TM [1 ]
Grulet, OMC [1 ]
Rizos, H [1 ]
Kefford, RF [1 ]
机构：
[1] Univ Sydney, Westmead Hosp, Westmead Inst Canc Res, Westmead, NSW 2145, Australia
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 1997年 / 61卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
397
引用
收藏
页码：A73 / A73
页数：1
相关论文
共 50 条
  • [31] Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma
    Forschner, Andrea
    Sinnberg, Tobias
    Mroz, Gabi
    Schroeder, Christopher
    Reinert, Christian Philipp
    Gatidis, Sergios
    Bitzer, Michael
    Eigentler, Thomas
    Garbe, Claus
    Niessner, Heike
    Rocken, Martin
    Roggia, Cristiana
    Armeanu-Ebinger, Sorin
    Riess, Olaf
    Mattern, Sven
    Nann, Dominik
    Bonzheim, Irina
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] CDKN2A/p16, RB and CDK4 alterations in osteosarcoma
    Nielsen, GP
    Burns, K
    Rosenberg, AE
    Louis, DN
    MODERN PATHOLOGY, 1998, 11 (01) : 13A - 13A
  • [33] CDKN2A mutation analysis in patients with melanoma and breast cancer
    Nagore, E.
    Botella-Estrada, R.
    Garcia-Casado, Z.
    Chirivella, I
    Soriano, V
    Lluch, A.
    Guillen, C.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2007, 299 (5-6) : 292 - 292
  • [34] CDKN2A and CDK4 mutations in two unrelated British melanoma-prone families and implications for genetic testing
    Lai-Cheong, J.
    Pichert, G.
    Acland, K. M.
    Whittaker, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 : 57 - 57
  • [35] Variation in Cutaneous Patterns of Melanomagenesis According to Germline CDKN2A/CDK4 Status in Melanoma-Prone Families
    Sargen, Michael R.
    Pfeiffer, Ruth M.
    Yang, Xiaohong R.
    Tucker, Margaret A.
    Goldstein, Alisa M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (01) : 174 - +
  • [36] Genotype-phenotype relationships in American melanoma-prone families with CDKN2A and CDK4 mutations.
    Goldstein, AM
    Struewing, JP
    Chidambaram, A
    Fraser, MC
    Tucker, MA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A128 - A128
  • [37] CDKN2A/p16, RB and CDK4 alterations in osteosarcoma.
    Nielsen, GP
    Burns, K
    Rosenberg, AE
    Louis, DN
    LABORATORY INVESTIGATION, 1998, 78 (01) : 13A - 13A
  • [38] Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A
    Javier Martin-Broto
    Jeronimo Martinez-Garcia
    David S. Moura
    Andres Redondo
    Antonio Gutierrez
    Antonio Lopez-Pousa
    Javier Martinez-Trufero
    Isabel Sevilla
    Roberto Diaz-Beveridge
    Maria Pilar Solis-Hernandez
    Amancio Carnero
    Marco Perez
    David Marcilla
    Jesus Garcia-Foncillas
    Pablo Romero
    Javier Fernandez-Jara
    Daniel Lopez-Lopez
    Ivan Arribas
    Nadia Hindi
    Signal Transduction and Targeted Therapy, 8
  • [39] Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A
    Martin-Broto, Javier
    Martinez-Garcia, Jeronimo
    Moura, David S.
    Redondo, Andres
    Gutierrez, Antonio
    Lopez-Pousa, Antonio
    Martinez-Trufero, Javier
    Sevilla, Isabel
    Diaz-Beveridge, Roberto
    Solis-Hernandez, Maria Pilar
    Carnero, Amancio
    Perez, Marco
    Marcilla, David
    Garcia-Foncillas, Jesus
    Romero, Pablo
    Fernandez-Jara, Javier
    Lopez-Lopez, Daniel
    Arribas, Ivan
    Hindi, Nadia
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [40] Association Of Genetic Variants With The Risk Of Dysplastic Nevi In Melanoma-Prone Families With And Without CDKN2A/CDK4 Mutations
    Liang, Xueying
    Pfeiffer, Ruth M.
    Wheeler, William
    Maeder, Dennis
    Burdette, Laurie
    Meredith, Yeager
    Chanock, Stephen
    Margaret, Tucker A.
    Goldstein, Alisa M.
    Yang, Xiaohong R.
    GENETIC EPIDEMIOLOGY, 2012, 36 (02) : 128 - 128
12345